| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 663,176 | 678,385 | 682,014 | 696,259 | | Cost of Revenue | 814,561 |
-
|
-
| 276,207 | | | Gross Profit | (151,385) | 678,385 | 682,014 | 420,052 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (497,993) | 319,929 | 358,445 | 44,862 | | Non Recurring |
-
|
-
|
-
| 73,438 | | Others | 129,409 | 137,317 | 132,119 | 139,164 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 217,199 | 221,139 | 191,450 | 162,588 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (54,977) | (94,940) | 117,737 | (77,071) | | Earnings Before Interest And Taxes | 278,039 | 126,199 | 309,187 | (70,756) | | Interest Expense | 166,204 | 161,117 | 147,707 | 142,506 | | Income Before Tax | 111,835 | (34,918) | 161,480 | (213,262) | | Income Tax Expense | 5,267 | 5,457 | 5,049 | 2,633 | | Minority Interest | (28,808) |
-
|
-
| (42,567) | | | | Net Income From Continuing Ops | 106,568 | (40,375) | 156,431 | (259,016) | | | Non-recurring Events | | Discontinued Operations | 49,276 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| 56,501 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 127,036 | (40,375) | 156,431 | (202,515) | | Preferred Stock And Other Adjustments | (688) | (11,529) | (30,590) | (14,271) | | | Net Income Applicable To Common Shares | $126,348 | ($51,904) | $125,841 | ($216,786) |
|
0.29% Nasdaq 
Income Statement
